Crossmark

Pluvicto® - die erste Radioligandentherapie

Crossref DOI link: https://doi.org/10.1007/s15004-023-9990-1

Published Online: 2023-07-25

Published Print: 2023-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Springer, Günter
License Information

Text and Data Mining valid from 2023-07-01

Version of Record valid from 2023-07-01
More Information

Article History

First Online: 25 July 2023

Free to read: This content has been made available to all.